Evidence map›Paper›PMID 39669588›Full record

ArticleGenetics in medicine open2024

Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes.

Nihat B Agaoglu, Brittany L Bychkovsky, Carolyn Horton, Min-Tzu Lo, Linda Polfus, Cassidy Carraway, Parichehr Hemyari, Colin Young, Marcy E Richardson, Rochelle Scheib and 2 more

Abstract read
In one paragraph

Article in Genetics in medicine open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nihat B AgaogluDivision of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.
Brittany L BychkovskyDivision of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.
Carolyn HortonAmbry Genetics, Aliso Viejo, CA.
Min-Tzu LoAmbry Genetics, Aliso Viejo, CA.
Linda PolfusAmbry Genetics, Aliso Viejo, CA.
Cassidy CarrawayAmbry Genetics, Aliso Viejo, CA.
Parichehr HemyariAmbry Genetics, Aliso Viejo, CA.
Colin YoungAmbry Genetics, Aliso Viejo, CA.
Marcy E RichardsonAmbry Genetics, Aliso Viejo, CA.
Rochelle ScheibDivision of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.
Judy E GarberDivision of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.
Huma Q RanaDivision of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: As panel testing expands, more individuals with double pathogenic variants (DPVs) in cancer susceptibility genes are likely to be identified. Little is known about the effects of DPVs on cancer phenotype, although this information is crucial for genetic counseling and risk management. We sought to describe the cancer phenotype among individuals with DPVs in cancer susceptibility genes. Methods: A retrospective study of individuals with DPVs identified through a single testing laboratory from 2012 to 2017 was conducted. DPV combinations were enumerated. For DPV gene combinations that occurred >10 times, cancer histories of individuals with DPVs were compared with cancer histories of controls with a single PV matched by gene. Results: Among 644 individuals with DPVs, combinations that included the Conclusion: Individuals with

Indexed as

Breast cancerGeneticsGermlineHereditary cancerMultiple pathogenic variants

Identifiers

PMID39669588
PMCPMC11613565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.